These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34124630)

  • 21. Medical doctors profile in Ethiopia: production, attrition and retention. In memory of 100-years Ethiopian modern medicine & the new Ethiopian millennium.
    Berhan Y
    Ethiop Med J; 2008 Jan; 46 Suppl 1():1-77. PubMed ID: 18709707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey.
    Hoballah A; El Haidari R; Siblany G; Abdel Sater F; Mansour S; Hassan H; Abou-Abbas L
    BMC Infect Dis; 2022 Jan; 22(1):42. PubMed ID: 35012464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis.
    Bobrovitz N; Arora RK; Cao C; Boucher E; Liu M; Donnici C; Yanes-Lane M; Whelan M; Perlman-Arrow S; Chen J; Rahim H; Ilincic N; Segal M; Duarte N; Van Wyk J; Yan T; Atmaja A; Rocco S; Joseph A; Penny L; Clifton DA; Williamson T; Yansouni CP; Evans TG; Chevrier J; Papenburg J; Cheng MP
    PLoS One; 2021; 16(6):e0252617. PubMed ID: 34161316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in the Mozambican Population: A Cross-Sectional Serologic Study in 3 Cities, July-August 2020.
    Arnaldo P; Mabunda N; Young PW; Tran T; Sitoe N; Chelene I; Nhanombe A; Ismael N; Júnior A; Cubula B; Inlamea OF; Gudo E; Jani IV
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S285-S293. PubMed ID: 35748663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ) IgG-antibody seroprevalence among quarantined population, during the first wave of COVID-19 pandemic, In North West Ethiopia (from 30 April to 30 May 2020).
    Kebede F; Kebede T; Kebede B
    SAGE Open Med; 2022; 10():20503121221076931. PubMed ID: 35154744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.
    Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM
    JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
    Pollán M; Pérez-Gómez B; Pastor-Barriuso R; Oteo J; Hernán MA; Pérez-Olmeda M; Sanmartín JL; Fernández-García A; Cruz I; Fernández de Larrea N; Molina M; Rodríguez-Cabrera F; Martín M; Merino-Amador P; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Yotti R;
    Lancet; 2020 Aug; 396(10250):535-544. PubMed ID: 32645347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and factors associated with substance use among street children in Jimma town, Oromiya national regional state, Ethiopia: a community based cross-sectional study.
    Ayenew M; Kabeta T; Woldemichael K
    Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):61. PubMed ID: 32819391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogenous transmission and seroprevalence of SARS-CoV-2 in two demographically diverse populations with low vaccination uptake in Kenya, March and June 2021.
    Munywoki PK; Bigogo G; Nasimiyu C; Ouma A; Aol G; Oduor CO; Rono S; Auko J; Agogo GO; Njoroge R; Oketch D; Odhiambo D; Odeyo VW; Kikwai G; Onyango C; Juma B; Hunsperger E; Lidechi S; Ochieng CA; Lo TQ; Munyua P; Herman-Roloff A
    Gates Open Res; 2023; 7():101. PubMed ID: 37990692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data.
    Barchuk A; Skougarevskiy D; Kouprianov A; Shirokov D; Dudkina O; Tursun-Zade R; Sergeeva M; Tychkova V; Komissarov A; Zheltukhina A; Lioznov D; Isaev A; Pomerantseva E; Zhikrivetskaya S; Sofronova Y; Blagodatskikh K; Titaev K; Barabanova L; Danilenko D
    PLoS One; 2022; 17(6):e0266945. PubMed ID: 35704649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Escalating spread of SARS-CoV-2 infection after school reopening among students in hotspot districts of Oromia Region in Ethiopia: Longitudinal study.
    Gobena D; Kebede Gudina E; Yilma D; Girma T; Gebre G; Gelanew T; Abdissa A; Mulleta D; Sarbessa T; Asefa H; Woldie M; Shumi G; Kenate B; Kroidl A; Wieser A; Eshetu B; Degfie TT; Mekonnen Z
    PLoS One; 2023; 18(2):e0280801. PubMed ID: 36735689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamics of SARS-CoV-2 seroprevalence during the first year of the COVID-19 pandemic in the Northeast region of Brazil.
    de Souza Araújo AA; Quintans-Júnior LJ; Heimfarth L; Schimieguel DM; Corrêa CB; de Moura TR; Cavalcante RCM; Grespan R; de Souza Siqueira Quintans J; Dos Santos DM; da Silva DN; de Oliveira YLM; de Franca MNF; da Conceição Silva M; de Sá DLF; de Carvalho FO; de Souza MF; de Oliveira Góes MA; Santos VS; Martins-Filho PR
    Pathog Glob Health; 2023 Jul; 117(5):505-512. PubMed ID: 36094065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating diagnostic accuracies of Panbio™ test and RT-PCR for the detection of SARS-CoV-2 in Addis Ababa, Ethiopia using Bayesian Latent-Class Models (BLCM).
    Sisay A; Hartnack S; Tiruneh A; Desalegn Y; Tesfaye A; Desta AF
    PLoS One; 2022; 17(10):e0268160. PubMed ID: 36260547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 Serosurvey in Addis Ababa, Ethiopia.
    Kempen JH; Abashawl A; Suga HK; Nigussie Difabachew M; Kempen CJ; Tesfaye Debele M; Menkir AA; Assefa MT; Asfaw EH; Habtegabriel LB; Sitotaw Addisie Y; Nilles EJ; Longenecker JC
    Am J Trop Med Hyg; 2020 Nov; 103(5):2022-2023. PubMed ID: 32975182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.
    Mutevedzi PC; Kawonga M; Kwatra G; Moultrie A; Baillie V; Mabena N; Mathibe MN; Rafuma MM; Maposa I; Abbott G; Hugo J; Ikalafeng B; Adelekan T; Lukhele M; Madhi SA
    Int J Epidemiol; 2022 May; 51(2):404-417. PubMed ID: 34718591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline Seroprevalence of SARS-CoV-2 Specific Antibodies in Hot Spot Areas of Great Tunis, up to 3 Months Post Disease Onset in Tunisia.
    Dhaouadi S; Letaief H; Hechaichi A; Safer M; Moussa R; Bouhali R; Letaief F; Abdelkader L; Ben Salah H; El Mili N; Hammami M; Talmoudi K; Souteyrand Y; Nabeth P; Kouni Chahed M; Bouafif Ép Ben Alaya N
    Epidemiologia (Basel); 2023 Jun; 4(2):188-201. PubMed ID: 37367185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia.
    Janha RE; Bah A; Jah H; Touray F; Idris Y; Keita S; Gaye Y; Jallow S; Faye-Joof T; Njie B; Craik R; Mohammed NI; von Dadelszen P; D'Alessandro U; Roca A;
    Int J Infect Dis; 2023 Oct; 135():109-117. PubMed ID: 37586660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.